Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rose Travers

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Bone|September 16, 2005
The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type VLeonid Zeitlin, Frank Rauch, Rose Travers, et al.
Pediatrics|July 3, 2002
Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of ageAlexandre Lapillonne, Rose Travers, Massimo DiMaio, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of boneHoracio Plotkin, Frank Rauch, Leonid Zeitlin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defectFrancis H Glorieux, Leanne M Ward, Frank Rauch, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2011
Mutations in SERPINF1 cause osteogenesis imperfecta type VIErica P Homan, Frank Rauch, Ingo Grafe, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Bone|September 16, 2005
The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type VLeonid Zeitlin, Frank Rauch, Rose Travers, et al.
Pediatrics|July 3, 2002
Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of ageAlexandre Lapillonne, Rose Travers, Massimo DiMaio, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of boneHoracio Plotkin, Frank Rauch, Leonid Zeitlin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defectFrancis H Glorieux, Leanne M Ward, Frank Rauch, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2011
Mutations in SERPINF1 cause osteogenesis imperfecta type VIErica P Homan, Frank Rauch, Ingo Grafe, et al.
Pageof 2